Multicenter phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG) Meeting Abstract

  

Authors:	Lin, X.; Kaley, T. J.; Pentsova, E.; DeAngelis, L. M.; Daras, M.; Gavrilovic, I. T.; Mellinghoff, I. K.; McKeown, A.; Manne, M.; Hansen, J.; Bavisotto, L. M.; Gorman, G.; Lamson, M.; Karmali, R. A.; Omuro, A. M. P.
Abstract Title:	Multicenter phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG)
Meeting Title:	52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	34
Issue:	15 Suppl.
Meeting Dates:	2016 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2016-05-20
Start Page:	108s
Language:	English
ACCESSION:	WOS:000404665403051
DOI:	10.1200/JCO.2016.34.15_suppl.2064
PROVIDER:	wos
Notes:	Meeting Abstract: 2064 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/155006